Parents Sought Stricter Kratom Regulations After Son's Death
The Knox family is challenging 7-OH product safety following a fatal overdose in South Carolina.
Updated on Sept. 23, 2026 in Substance Abuse
Following the June 26, 2026, death of 29-year-old Micah Knox, his family is pursuing legal action against manufacturers of the kratom-derived product 7-OH. The family is advocating for tighter controls on the substance, which is currently legal for purchase by adults 21 and older across South Carolina.
Why it matters
The case highlights concerns over the lack of federal and state regulation for 7-OH, which the family believes poses an ongoing risk to residents. They are pushing to hold distributors accountable in hopes of preventing further deaths linked to mitragynine-containing products.
DEA surveillance identified mitragynine in 51 overdose cases between 2025 and April 2026. While the substance was confirmed in the blood of Micah Knox, the broader impact and safety profile of these products remain under active investigation.
The players
Micah Knox
A 29-year-old South Carolina resident who died following an overdose involving mitragynine.
Drug Enforcement Administration
The federal agency tasked with enforcing controlled substances laws and tracking emerging drug trends through toxicology programs.
The details
7-OH is a kratom-derived compound frequently sold in smoke shops and gas stations. Lawmakers in South Carolina previously considered but failed to pass legislation that would have established regulatory limits on the levels of mitragynine in such products. The Knox family is now collaborating with attorneys to challenge current distribution practices.
Timeline
51 overdose cases involving mitragynine were detected between 2025 and April 2026.
Micah Knox died on June 26, 2026.
Potential legislative action on kratom is expected in the next session next year.
Health Landscape
The current push for regulation follows a failed attempt by South Carolina lawmakers to pass legislation governing mitragynine levels. This case underscores the ongoing gap in federal oversight for 7-OH products sold in retail environments.
Residents should remain aware that 7-OH products currently lack federal safety standards despite being available for legal purchase. If you have concerns about the use of these substances, it is worth discussing the potential risks with your primary care physician.
The takeaway
The recent death of Micah Knox has brought urgent attention to the risks associated with unregulated 7-OH products. It is important to treat any supplement or store-bought substance with caution and consult with a doctor before use, especially given the lack of consistent federal oversight.
What happens next
The state legislature is expected to reconsider potential bills regarding kratom regulation in the next session next year.
Further reading
For more context on how state policies address emerging substances, visit the Substance Abuse section.
Source note: This article includes information reported by Kwtx.
